CDKN2B-AS1 and metastatic malignant neoplasm in the lymph nodes: A high level of ANRIL expression was also associated with the tumor size (small vs large, odds ratio [OR] = 0.57, 95% CI: 0.39–0.83, P = .003), TNM stage (I + II vs III + IV; OR = 0.40, 95% CI: 0.24–0.69, P = .0008), and lymph node metastasis (LNM) (Yes vs No, OR = 3.66, 95% CI: 1.46–9.17, P = .006).